ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,837.57
-0.57%
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs Yen
155.898
0.30%
Brent Oil
84.095
0.64%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Eyegate Pharmaceuticals Inc (EYEGW)

  7. Eyegate Pharmaceuticals Inc (EYEGW) ニュース

EYEGW

Eyegate Pharmaceuticals (EYEGW)

Eyegate Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:EYEGW
日付受信時刻ニュースソース見出しコード企業名
2016/09/2121 : 30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/09/1321 : 30GlobeNewswire Inc.EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of DefenseNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/09/1221 : 30GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/09/0621 : 30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/08/1105 : 50GlobeNewswire Inc.EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/08/0121 : 30GlobeNewswire Inc.EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammat...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/07/0102 : 00GlobeNewswire Inc.EyeGate Announces Completion of $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/06/2721 : 00GlobeNewswire Inc.EyeGate Announces $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/06/0121 : 30GlobeNewswire Inc.EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation an...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/05/2507 : 00GlobeNewswire Inc.EyeGate Pharma Announces At The Market Issuance ProgramNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/05/1406 : 25GlobeNewswire Inc.Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/05/0621 : 30GlobeNewswire Inc.EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and DevelopmentNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/04/2900 : 46GlobeNewswire Inc.EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-SNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/04/2805 : 05GlobeNewswire Inc.EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial OfficerNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/03/3005 : 45GlobeNewswire Inc.EyeGate Reports Full-year 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/03/1009 : 46GlobeNewswire Inc.EyeGate Pharma Acquires Jade TherapeuticsNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/03/1009 : 46GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/01/1922 : 30GlobeNewswire Inc.EyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior UveitisNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2016/01/1423 : 49GlobeNewswire Inc.Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2015/11/1222 : 30GlobeNewswire Inc.EyeGate Reports Third Quarter 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
2015/11/0522 : 45GlobeNewswire Inc.EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial of Iontophoretic EGP-437 Ophthalmic Solution in Macular Edem...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
2015/10/1521 : 30GlobeNewswire Inc.EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery SystemNASDAQ:EYEGWEyegate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EYEGW

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
USOTC
ADDYY
Adidas (QX)
AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
SPI
SP500
S&P 500
NYSE
BAC
Bank of America
NASDAQ
GOOGL
Alphabet
CCOM
US30
US 30
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有